BioSyent Inc. (RX.V)
| Previous close | 8.45 |
| Open | 8.53 |
| Bid | 8.53 x 0 |
| Ask | 8.60 x 0 |
| Day's range | 8.53 - 8.58 |
| 52-week range | 7.03 - 9.26 |
| Volume | |
| Avg. volume | 5,206 |
| Market cap | 99.61M |
| Beta (5Y monthly) | 0.93 |
| PE ratio (TTM) | 16.19 |
| EPS (TTM) | 0.53 |
| Earnings date | 24 May 2024 - 28 May 2024 |
| Forward dividend & yield | 0.18 (2.13%) |
| Ex-dividend date | 28 Feb 2024 |
| 1y target est | 9.00 |
GlobeNewswireBioSyent Announces Extension of RepaGyn® and Proktis-M® Agreement
MISSISSAUGA, Ontario, April 15, 2024 (GLOBE NEWSWIRE) -- BioSyent Inc. (“BioSyent”, “the Company”, TSX Venture: RX) is pleased to announce that its wholly-owned subsidiary, BioSyent Pharma Inc. (“BioSyent Pharma”), has extended its Exclusive License and Distribution Agreement with its European partner for the RepaGyn® and Proktis-M® products, extending BioSyent Pharma’s exclusive Canadian rights to these products until 2032. “RepaGyn® and Proktis-M® have been part of our product portfolio since
- GlobeNewswire
BioSyent to Present at 2024 Bloom Burton & Co. Healthcare Investor Conference
MISSISSAUGA, Ontario, April 10, 2024 (GLOBE NEWSWIRE) -- BioSyent Inc. (“BioSyent”, TSX Venture: RX) is pleased to announce that it will be presenting at the upcoming 2024 Bloom Burton & Co. Healthcare Investor Conference. The conference will be held in Toronto at the Metro Toronto Convention Centre (North Building) on Tuesday, April 16 and Wednesday, April 17, 2024. Mr. René Goehrum, President and CEO of BioSyent, will present to investors an overview of BioSyent’s business and corporate activi
- GlobeNewswire
FeraMAX® Named #1 Recommended Iron Supplement in Canada by Pharmacists and Physicians for Ninth Consecutive Year
MISSISSAUGA, Ontario, April 03, 2024 (GLOBE NEWSWIRE) -- BioSyent Inc. (“BioSyent”, TSX Venture: RX) is pleased to announce that FeraMAX® is the #1 recommended iron supplement brand in Canada, based on a national survey of Canadian pharmacists and physicians(1). This year marks the ninth consecutive year that FeraMAX® has been awarded this vote of confidence from physicians and pharmacists across Canada, including those professionals in Quebec. The annual Survey on OTC Counselling and Recommenda
